Myasthenia Gravis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You are able to understand what the study involves and are willing to sign a consent form
If you have Myasthenia Gravis (MG):
- You have been formally diagnosed with myasthenia gravis (either affecting only the eyes, or more widespread), classified as "definite" or "probable" according to Dutch national guidelines
- Your MG severity falls within a certain range on a standard medical scale (levels I through IV) (confirm with trial site)
- You currently experience at least one of these symptoms: slurred speech, changes to your voice, weakness in your upper arms, and/or drooping eyelids
If you do not have Myasthenia Gravis:
- You have not been diagnosed with MG and there is no medical reason to suspect you have it
- You have no history of slurred speech, voice changes, upper arm weakness, or drooping eyelids
Who may not be able to join:
- You are not willing to have your voice recorded during the study
- You are not willing to be filmed during the study
- You are currently taking part in another clinical trial involving an experimental medicine
- You have taken a short-acting pyridostigmine-based medication in the 12 hours before taking part, or you currently take a long-acting version of this medication
- You have cognitive or physical difficulties that would prevent you from completing the study tasks, in the opinion of the study doctor
If you have Myasthenia Gravis:
- You have had an arm amputated or are unable to speak
- You have another diagnosed neurological condition (separate from MG) that causes muscle weakness
If you do not have Myasthenia Gravis:
- You have any condition that limits the movement of your arms or affects your ability to speak
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Martijn R. Tannemaat, MD, PhD, Leiden University Medical Center
Phone: +31715262197
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Differentiating between MG-patients and non-MG participants using digital features of dysarhtria, dysphonia, proximal arm fatigue and ptosis.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.